AnsfieldF. J., SchroederJ. M., CurreriA. R.: Five years clinical experience with 5-Fluourouracil. JAMA, 181: 295–299, 1962.
2.
BajettaE., de PaloG. M., LucianiL., BonadonnaG.: Controlled study with Adriamycin (ADM) plus Bleomycin (BLM) versus Cyclophosphamide (CTX) plus Vincristine (VCR) in advanced carcinoma of the cervix. Vol. 1. Abstr. Workshop 3, pp. 255. Proc. XI International Cancer Congress, Florence, 1974.
3.
BarlowJ. J., PiverM. S., ChuangT., CortesE. P., OhnumaT., HollandJ. F.: Adriamycin and Bleomycin, alone and in combination, in gynecological cancers. Cancer, 32: 735–743, 1973.
4.
BashoreR. A., LagasseL. D.: Continuous infusion of advanced pelvic malignancies by retrograde femoral catheter. Surg. Forum, 14: 402–403, 1963.
5.
BatemanJ. C., CarltonH. N., ThibeaultJ. P.: Chemotherapy for carcinoma of the uterus. Obstet. Gynec., 15: 35–42, 1960.
6.
BatemanJ. R., HazenJ. G., StolinskyD. C., SteinfeldJ. L.: Advanced carcinoma of the cervix treated by intra-arterial methotrexate. Am. J. Obstet. Gynec., 96: 181–187, 1966.
7.
BergevinP. R., TormeyD. C., BlumJ.: Clinical evaluation of hexamethylmelanine (NSC 13875). Cancer Res., 57: 51–58, 1973.
8.
BlumR. H., CarterS. K., AgreK.: A clinical review of Bleomycin, a new antineoplastic agent. Cancer, 31: 903–914, 1973.
9.
BlumR. H., LivingstonR. B., CarterS. K.: Hexamethylmelamine. A new drug with activity in solid tumors. Eur. J. Cancer, 9: 977–979, 1973.
10.
BoimanR. E., HolzaepfelJ. H., BarnesA. C.: Intra-arterial nitrogen mustard in advanced pelvic malignancies. Am. J. Obstet. Gynec.72: 1319–1325, 1956.
11.
BonadonnaG., BerettaG., TanciniC., BrambillaC., BajettaE., de PaloG. M., De LenaM., Fossati-BellaniF., GaspariniM., ValagussaP., VeronesiU.: Adriamycin (NSC-123127) Studies at the Istituto Nazionale Tumori, Milan. Cancer Chemother. Rep., 6: 231–245, 1975.
12.
BondW. H., ArthurK., BanksA. J., FreemanW. E., HolmeG. M., News-holmeG. A., WardH. W. C., JonesW. G., ChowdhuryM. S., BrownI.: Combination chemotherapy in the treatment of advanced squamous cell carcinoma of the cervix. Clin. Oncol., 2: 173–178, 1976.
13.
BurnJ. I., JohnstonI. D. A., DaviesA. J., SellwoodR. A.: Cancer chemotherapy by continuous intra-arterial infusion of methotrexate. Br. J. Surg., 53: 329–336, 1966.
14.
ByronR. L.Jr., SinghB. P., BiermanH. R., KellyK. H.: Intra-aortic nitrogen mustard therapy in advanced pelvic malignancies. Surgery, 45: 634–641, 1959.
15.
CavanaghD., MartinD. S., Hernandez-RomanP.: Closed pelvic perfusion. A new approach to the problem of advanced gynecologic malignancy. Am. J. Obstet. Gynec., 92: 996–1005, 1965.
16.
Clinical Screening Cooperative Group of the EORTC: Study of the clinical efficiency of bleomycin in human cancer. Br. Med. J., 2: 643–645, 1970.
17.
ColonJ., MayerM., FisherG.: Indications de la chimiothérapie intra-artérielle dans les cancers pelviens. Bull. Ass. Franç. Cancer, 51: 379–393, 1964.
18.
ColonJ., MayerM., DargentM.: La chimiothérapie régionale par voie intraartérielle dans le traitement des cancers pelviens en phase avancée. Lyon Chirurgical, 58: 926–935, 1962.
19.
ConroyJ. F., LewisG. C., BradyL. W., BrodskyI., KalmS. B., RossD., NussR.: Low-dose Bleomycin and Methotrexate in cervical cancer. Cancer, 37: 660–664, 1976.
20.
CostanziJ. J., ColtmanC. A.: Combination chemotherapy using cyclophosphamide, vincristine, methotrexate and 5-fluorouracil in solid tumors. Cancer, 23: 589–596, 1969.
CreechO. J.Jr., KrementzE. T., RyanR. F., ReemtsmaK., WinbladJ. N., ElliotJ. L.: The treatment of cancer by perfusion. Arch. Surg., 79: 963–975, 1959.
23.
CromerJ. K., BatemanJ. C., BerryG. N., KennellyJ. M., KloopC. T., PlattL.I.: Use of intra-arterial nitrogen mustard therapy in the treatment of cervical and vaginal cancer. Am. J. Obstet. Gynec., 63: 538–543, 1952.
24.
CvitkovicE., CurrieW., OchoaM., PrideG., KrakoffI. H.: Continuous intravenous infusion of Bleomycin in squamous cancer. AACR and ASCO Meetings, Abstr. 780, pp. 179, 1974.
25.
de PaloG. M., BajettaE., LucianiL., MusumeciR., Di ReF., BonadonnaG.: Methotrexate (NSC-740) and Bleomycin (NSC-125066) in the treatment of advanced epidermoid carcinoma of uterine cervix. Cancer Chemother. Rep., 57: 429–435, 1973.
26.
de PaloG. M., BajettaE., BerettaG., BonadonnaG.: Adriamycin plus Bleomycin versus Cyclophosphamide plus Vincristine in advanced carcinoma of the uterine cervix. Tumori, 62: 113–122, 1976.
27.
EaganR. T., MaurerL. H., ForcierR. J.: Chemotherapy of recurrent carcinoma of the cervix, a preliminary report. Cancer Chemother. Rep., 57: 90(Abstr. 6), 1973.
28.
ForneyJ. P., MorrowP. C., Di SaiaP. J., FutoranR. J.: Seven-drug poly-chemotherapy in the treatment of advanced and recurrent squamous carcinoma of the female genital tract. Am. J. Obstet. Gynec., 123: 748–752, 1975.
29.
FrickH. C. I.I., AtchooU., AdamsonsK.Jr., TaylorH. C.: The efficacy of chemotherapeutic agents in the management of disseminated gynecologic cancer. Am. J. Obstet. Gynec., 93: 1112–1121, 1965.
30.
GuthrieD., WayS.: Treatment of advanced carcinoma of the cervix with Adriamycin and Methotrexate combination. Obstet. Gynec., 44: 586–589, 1974.
31.
HallT. C., KramtM. J., LloydJ. B., Bradford PattersonW., IshiharaA., GalepoteeK., LovimaT. O., MullemJ. M.: Treatment of localized inoperable neoplasms with intra-arterial infusion of 8-azoguanine. Cancer, 15: 1156–1164, 1962.
32.
HallB. E., GoodJ. W.: Treatment of far-advanced cancer with 5-fluorouracil used alone and in combination with irradiation. Incidence and duration of remission and survival-time; data in 223 patients. Cancer Chemother. Rep., 16: 369–386, 1962.
33.
HerterF. P., MalmJ. R., MarkowitzA.M., DemetzA., EvansS.: Cancer chemotherapy by regional perfusion. N.Y. State J. Med., 62: 465–479, 1962.
34.
HerterF. P., MarkowitzA. M., FeindC. R.: Cancer chemotherapy by continuous intra-arterial infusion of antimetabolites. Am. J. Surg., 105: 628–639, 1963.
35.
HodgkinsonC. P., BoyceC. R.: Prolonged intra-arterial therapy for advanced pelvic malignancy. Cancer, 18: 1536–1543, 1965.
36.
HreshchyshynM. M., HollandJ. F.: Chemotherapy in patients with gynecologic cancer. Am. J. Obstet. Gynec., 83: 468–489, 1962.
37.
HreshchyshynM. M.: Vincristine treatment of patients with carcinoma of the uterine cervix. Proc. Am. Ass. Cancer Res., 4: 29(Abstr. 114), 1963.
38.
HreshchyshynM. M.: Experiences with chemotherapy in gynecologic cancer. N.Y. State J. Med., 64: 2431–2434, 1964.
39.
HulkaJ. F., BiselH. F.: Combined intra-arterial chemotherapy and radiation treatment for advanced cervical carcinoma. The Mc Call technique and results. Am. J. Obstet. Gynec., 91: 486–490, 1965.
40.
KatoT., AbeH., YamagamiT., UchinoM.: Therapeutic effects of Bleomycin, an anticarcinogenetic agent, on cancers occurred in the female genital organs. Kurume Med. J., 17: 75–95, 1970.
41.
KennedyB. J., TheologidesA.: The role of 5-fluorouracil in malignant disease. Ann. Int. Med., 55: 719–730, 1961.
42.
KloopC. T., AlfordT. C., BatemanJ., BerryG. N., WinshipT.: Fractionated intra-arterial cancer chemotherapy with methyl-bis-amine-hydrochloride; a preliminary report. Ann. Surg., 132: 811–832, 1950.
43.
KrakoffI. M., SullivanR. D.: Intra-arterial nitrogen mustard in pelvic carcinoma. Ann. Int. Med., 48: 839–846, 1958.
44.
LawrenceW.Jr.: Current status of regional chemotherapy. Part I: Technics. N. Y. State J. Med., 63: 2359–2382, 1963.
45.
LawrenceW.Jr.: Current status of regional chemotherapy. Part II: Results. N. Y. State J. Med., 63: 2518–2534, 1963.
46.
LaufeL. E., BlocksteinR. S., ParsiF. Z., LowyA. D.Jr.: Infusion through inferior gluteal artery for pelvic cancer. A preliminary report. Obstet. Gynec., 28: 650–659, 1966.
47.
LourosN., PapavasiliouC., DeliyannisE.: Palliative treatment of advanced cervical carcinoma by intra-aortic injection of nitrogen mustard. I. Obstet. Gynec. Brit. CWLTH, 72: 610–613, 1965.
MalkasianG. D., DeckerD. G., MusseyE., JohnsonC. E.: Preliminary observations on carcinoma of the cervix treated with 5-Fluorouracil. Am. J. Obstet. Gynec., 88: 82–85, 1964.
50.
MartinD. S., MyersM. B., HobbsJ. C., GilsonA. J., ProutG. R.Jr., WhiteH. M.Jr.: Preliminary report on tourniquet for pelvic perfusion. AMA Arch. Surg., 84: 247–251, 1962.
51.
MastersonJ. C., NelsonJ. H.Jr.: The role of chemotherapy in the treatment of gynecologic malignancy. Am. I. Obstet. Gynec., 93: 1102–1111, 1965.
52.
MonfardiniS., de PaloG. M., BajettaE., VeronesiU.: Adriamycin (ADM) plus Bleomycin (BLM) versus Cyclophosphamide (CTX) plus Vincristine (VCR) in advanced carcinoma of the uterine cervix. Proc Am. Ass. Cancer Res., 15: 91(Abstr. 361), 1974.
53.
MooreM. R. R., NewtonK. A.: Palliation of malignant pelvic disease by intra-aortic injection of nitrogen mustard (NSC-762) or ethoglucid (NSC-80439). Cancer Chemother. Rep., 41: 19–22, 1964.
54.
MooreG. E., BrossI. D., AusmanR., NadlerS., JonesR.Jr., SlackN., RimmA. A.: Effects of 5-fluorouracil (NSC-19893) in 389 patients with cancer. Eastern Clinical Drug Evaluation Program. Cancer Chemother. Rep., 52: 641–643, 1968.
55.
MooreG. E., BrossI. D., AusmanR., NadlerS., JonesR.Jr., SlackN., RimmA. A.: Effects of 6-mercaptopurine (NSC-755) in 290 patients with advanced cancer. Eastern Clinical Drug Evaluation Program. Cancer Chemother. Rep., 52: 655–660, 1968.
56.
MooreG. E., BrossI. D., AusmanR., NadlerS., JonesR.Jr., SlackN., RimmA. A.: Effects of Chlorambucil (NSC-3088) in 374 patients with advanced cancer. Eastern Clinical Drug Evaluation Program. Cancer Chemother. Rep., 52: 661–666, 1968.
57.
MooreG. E., BrossI. D., AusmanR., NadlerS., JonesR.Jr., SlackN., RimmA. A.: Effects of Mitomycin C (NSC-26980) in 346 patients with advanced cancer. Eastern Clinical Drug Evaluation Program. Cancer Chemother. Rep., 52: 675–684, 1968.
58.
MorrowC. P., CreasmanW. T., Di SaiaP. J., CurryS. L., De PetrilloA. D.: Methotrexate, hydroxyurea and vincristine: combination chemotherapy in squamous carcinoma of the female genitalia. Gynec. Oncol., 1: 314–319, 1973.
59.
NathansonL., HallT. C., SchillingA., MillerS.: Concurrent combination chemotherapy of human solid tumors: experience with a three-drug regimen and review of the literature. Cancer Res., 29: 419–425, 1969.
60.
NewtonK. A.: Intermittent intra-arterial injection and continuous intravenous infusion in the treatment of advanced cancer. Proc. Roy. Soc. Med., 55: 646–649, 1962.
61.
NugmanovS. N., EsenkulovA. E.: Transumbilical catheterization of arteria iliaca interna for regional chemotherapy in cancer of the uterus. Neoplasma, 1: 649–656, 1967.
62.
O' BryanR. M., LuceJ. K., TalleyR. W., GottliebJ. A., BakerL. H., BonadonnaG.: Phase II evaluation of adriamycin in human neoplasia. Cancer, 32: 1–8, 1973.
63.
OmuraG. A., RobertsG. A.: Combination therapy of solid tumors using, 1,3-bis—(chloroethyl)-1-nitrosourea (BCNU), vincristine, methotrexate and 5-fluorouracil. Cancer, 31: 1374–1381, 1973.
64.
PanettiereF. J.: Porfiromycin therapy for disseminated cancer of the cervix and other organs. ASCO Abstracts (C-39), pp. 246, 1976.
65.
PapavasiliouC., AngelakisP., GouvalisP., PapakyriakidesL.: Treatment of cervical carcinoma by Methotrexate (NSC-740) combined with Cyclophosphamide (NSC-26271). Cancer Chemother. Rep., 53: 255–261, 1969.
66.
ParedesM., Quoted by Lawrence W. in: Current Status of Regional Chemotherapy. Part. I. Technics. N. Y. State J. Med., 63: 2359–2382, 1963.
67.
ParkerR. T., ShingletonW. W.: Chemotherapy in genital cancers: systemic therapy and regional perfusion. Am. J. Obstet. Gynec., 83: 981–1003, 1962.
68.
PiverS. M., BarlowJ. J., VongtamaV., WebsterP.: Hydroxyurea and radiation therapy in advanced cervical cancer. Am. J. Obstet. Gynec., 120: 969–972, 1974.
69.
RichardsonG. S., HallT. C., GreenT. H., UlfelderH.: Chemotherapy of cervical carcinoma. Ann. New York Acad. Sci., 97: 841–869, 1962.
70.
RiebelingM.: Massive intra-aortic injections of Nitrogen mustard (Dichloren), 5–Fluorouracil, Nitromen and Endoxan prior to Roentgen irradiation for advanced tumors of the uterus. Radiology, 79: 132–133, 1962.
71.
SeldingerS. I.: Catheter replacement of the needle in percutaneous arteriography. Acta Radiol., 39: 368–376, 1953.
72.
SeligmanA. G., UlfohnA., GabyS. D., GoodmanL. E., AybarO., KramerS. P., BakalD., HaberS., WilliamsonC. E., MillerJ. I., SassS., WittenB.: Enzyme alterable alkylating agents: a new approach to regional chemotherapy by intra-arterial infusion of new short-lived alkylating agents. Ann. Surg., 156: 429–441, 1962.
73.
SmithJ. P.: Infusion therapy for pelvic cancer. In: Cancer of the Uterus and Ovary. pp. 311–322. Eleventh Annual Clinical Conference on Cancer at the University of Texas M. D. Anderson Hospital and Tumor Institute - Houston. Year Book Medical Publishers Inc., Chicago, 1969.
74.
SmithJ. P., RutledgeF., BurnsB. C., SoffarS.: Systemic chemotherapy for carcinoma of the cervix. Am. J. Obstet. Gynec., 97: 800–807, 1967.
75.
SolidoroA. S., EstevesL., CastellanoC., ValdiviaE., BarrigaO.: Chemotherapy of advanced cancer of the cervix. Experience in 55 cases treated with cyclophosphamide. Am. J. Obstet. Gynec., 94: 208–213, 1966.
76.
StehlinJ. S.Jr., ClarkR. L.Jr., WhiteE. C., SmithJ. L.Jr., GriffinA. C., JesseR. H.Jr., HealeyJ. E.Jr.: Regional chemotherapy for cancer: experiences with 116 perfusions. Ann. Surg., 151: 605–619, 1960.
77.
StevensG. M., ThomasS. F., WilburB. C.: Intra-aortic nitrogen mustard for the palliation of advanced pelvic cancer. Radiology, 75: 948–953, 1960.
78.
StolinskyD. C., BogdonD. L., SolomonJ., BatemanJ. R.: Hexamethylmelamine (NSC-13875) alone and in combination with 5-3-3-dimethyltriazeno imidazole-4—carboxamide (NSC-45388) in the treatment of advanced cancer. Cancer, 30: 654–659, 1972.
79.
StolinskyD. C., BatemanJ. R.: Further experience with hexamethylmelamine (NSC-13875) in the treatment of carcinoma of the cervix. Cancer Chemother. Rep., 57: 497–499, 1973.
80.
SullivanR. D., MillerE., SikesM. P.: Antimetabolite-metabolite combination cancer chemotherapy; effects of intra-arterial methotrexate, intramuscular citrovorum factor therapy in human cancer. Cancer, 12: 1248–1262, 1959.
81.
SullivanR. D., WoodA. M., CliffordP., DuffJ. K., TrusselR., NaryD. J., BurchenalJ. H.: Continuous intra-arterial Methotrexate with simultaneous intermittent intramuscular citrovorum factor therapy in carcinoma of the cervix. Cancer Chemother. Rep., 8: 1–6, 1960.
82.
SullivanR. D., WatkinsE.Jr., GibbS. P.: Advances in the chemotherapy of solid tumors. Surg. Clin. N. Amer., 42: 807–822, 1962.
83.
TanL., EtcubanasE., WollnerN., RosenG., GilladogaA., ShowelJ., MurphyL. M., KrakoffI. H.: Adriamycin - an antitumor antibiotic in the treatment of neoplastic diseases. Cancer, 32: 9–17, 1973.
84.
TranumB. L., HautA., RivkinS., WeberE., QuaglianaJ. M., ShawM., TuckerW. G., SmithF. E., SamsonM., GottliebJ.: A Phase II study of Methyl—CCNU in the treatment of solid tumors and lymphomas: a Southwest Oncology Group Study. Cancer, 35: 1148–1153, 1975.
85.
TrussellR. R., Mitford-BarbertonG. De B.: Carcinoma of the cervix treated with continuous intra-arterial Methotrexate and intermittent intramuscular leucovorin. Lancet, 1: 971–975, 1961.
86.
WamplerG. L., MelletteS. J., KupermincM., RegelsonW.: Hexamethylmelamine (NSC-13875) in the treatment of advanced cancer. Cancer Chemother. Rep., 56: 505–514, 1972.
87.
WatkinsE., SullivanR. D.: Cancer chemotherapy by prolonged arterial infusion. Surg. Gynec. Obstet., 118: 3–19, 1964.
88.
WatkinsE.Jr., BeringA. C., LunaR., AdamsH. D.: The use of intravascular balloon catheters for isolation of the pelvic vascular bed during pump-oxygenator perfusion of cancer chemotherapeutic agents. Surg. Gynec. Obstet., 111: 464–468, 1960.
89.
WeissA. J., JacksonL. G., CarabasiR.: An evaluation of 5-fluorouracil in malignant disease. Ann. Int. Med., 55: 731–741, 1961.
90.
WilsonW. L., SchroederJ. M., BiselH. F., MrazekR., HummelR. P.: Phase II study of hexamethylmelamine (NSC-13875). Cancer, 23: 132–136, 1969.